Shanghai Medicilon Inc (688202)

Shanghai

Currency in CNY

58.93

-3.33(-5.35%)

Closed·07:56:57

Fair Value

Unlock Value

Day's Range

55.69

62.30

52 wk Range

23.30

71.71

688202 Financial Summary

A brief financial summary of Shanghai Medicilon Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-21.83

Price/Book3.37

Debt / Equity16.17%

Return on Equity-14.23%

Dividend Yield0.00%

EBITDA-281.18M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

665.96

1,167.26

1,658.93

1,365.63

1,037.75

Gross Profit

aa.aa

272.8

527.76

675.36

305.74

30.04

Operating Income

aa.aa

134.98

308.47

322.6

-84.17

-371.8

Net Income

aa.aa

129.39

282.22

338.24

-33.21

-330.85

Balance Sheet

Total Assets

aa.aa

1,364.32

1,793.57

2,329.58

3,265.85

2,823.26

Total Current Liabilities

aa.aa

196.14

383.66

617.04

686.36

576.15

Total Equity

aa.aa

1,135.65

1,327.51

1,602.78

2,510.78

2,140.16

Cash Flow

Levered Free Cash Flow

aa.aa

21.43

14.51

-583.36

-159.98

-78.05

Cash from Operations

aa.aa

207.77

452.94

-21.33

33.32

-22.75

Cash from Investing

aa.aa

-371.6

-399.55

-311.62

-787.55

-89.97

Cash from Financing

aa.aa

-1.9

-105.97

108.94

1,029.77

-106.71

Net Change in Cash

aa.aa

-170.84

-53.58

-215.84

275.34

-213.3

* In Millions of CNY (except for per share items)

Earnings

Latest Release

Apr 30, 2025

EPS / Forecast

-- / --

Revenue / Forecast

267.00M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What was Shanghai Medicilon's net income for the latest quarter?

Shanghai Medicilon's net income for the latest quarter was -202.17.

How did Shanghai Medicilon's performance compare year-over-year in the latest quarter?

The company's revenue moved from 280.30 in the previous quarter to 236.02 in the latest quarter, and net income moved from -58.44 to -202.17 compared to the previous quarter.

What is Shanghai Medicilon's net profit margin on a TTM basis?

Shanghai Medicilon's trailing twelve months (TTM) net profit margin is -31.88%.

How does Shanghai Medicilon's debt to equity ratio compare to industry standards?

Shanghai Medicilon's total debt-to-equity ratio is 16.17%.

What is Shanghai Medicilon's return on investment on a TTM basis?

Shanghai Medicilon's trailing twelve months (TTM) return on investment (ROI) is -14.23%.

Did Shanghai Medicilon gain or lose cash last quarter?

In the latest quarter, Shanghai Medicilon's net change in cash was -103.73 million.

What were Shanghai Medicilon's total assets and liabilities in the latest quarter?

As of the latest quarter, Shanghai Medicilon reported total assets of 2,823.26 million and total liabilities of 576.15 million.

How has Shanghai Medicilon's total revenue grown this year?

Shanghai Medicilon's total revenue was 280.30 in the previous quarter and 236.02 in the latest quarter.

What is Shanghai Medicilon's gross margin on a TTM basis?

Shanghai Medicilon's trailing twelve months (TTM) gross margin is 2.89%.

What was Shanghai Medicilon's revenue per share for the latest quarter?

Shanghai Medicilon's revenue per share for the latest quarter was 7.39.

NSE 30

5,152.36

-13.89

-0.27%

NSE All Share

141,248.77

-512.60

-0.36%

US 30

45,703.00

+137.9

+0.30%

US 500

6,485.60

+4.2

+0.07%

FTSE 100

9,258.00

+2.50

+0.03%

DAX

24,130.00

+76.49

+0.32%

South Africa Top 40

94,752.76

+390.34

+0.41%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	11.000	-1.79%	108.49M
Access Holdings	27.20	-1.09%	39.34M
First HoldCo	32.50	0.00%	35.78M
Aradel Holdings	510.00	0.00%	8.03M
BUA Foods	590.00	0.00%	2.33M
Nestle Nigeria	1,890.00	0.00%	676.78K
Seplat Petroleum	5,379.30	0.00%	489.84K

Name	Last	Chg. %	Vol.
Deap Capital Management Trust	1.74	+4.82%	2.55M
Honeywell Flour Mills Plc	22.500	+4.17%	1.51M
Tantalizers	2.59	+3.60%	2.35M
Afriprud	16.50	+3.13%	2.20M
UBA	49.50	+2.27%	6.87M
United Capital	19.300	+1.85%	2.81M
Oando Plc	53.95	+1.79%	4.42M

Name	Last	Chg. %	Vol.
Cornerst	6.39	-10.00%	1.70M
Rtbriscoe	3.06	-10.00%	2.44M
Abctrans	4.51	-9.80%	1.48M
Nigerian Exchange	53.55	-9.70%	1.45M
Mutual Benefits Assurance	4.06	-9.58%	16.53M
Caverton Offshore Support	6.400	-8.83%	7.05M
Sovereign Trust Insurance Plc	2.60	-8.77%	12.89M

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	14.95	-2.29%	10.57M
MTN Nigeria	435.00	0.00%	2.23M
Mutual Benefits Assurance	4.06	-9.58%	16.53M
VFD PLC	11.00	-5.98%	12.63M
Guaranty Trust Holding	95.00	-3.06%	9.37M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa	5,379.30	+46.90%	7,902.19
Aaaa A Aa Aaaa Aaa	520.00	+35.68%	705.54
Aaaaa A Aaaaa Aaa	1,890.00	+30.33%	2,463.24
Aaa Aaaaa Aaaa	151.80	+29.68%	196.85
Aaa Aaaaaaaaaaaaaaa	70.20	+26.05%	88.49
Aa Aaaaa Aaaaaaa	640.00	+21.59%	778.18

Name	Last	Upside	Fair Value
Aaaaaaaa	5,379.30	+46.90%	7,902.19
Aaaa A Aa Aaaa Aaa	520.00	+35.68%	705.54
Aaaaa A Aaaaa Aaa	1,890.00	+30.33%	2,463.24
Aaa Aaaaa Aaaa	151.80	+29.68%	196.85
Aaa Aaaaaaaaaaaaaaa	70.20	+26.05%	88.49
Aa Aaaaa Aaaaaaa	640.00	+21.59%	778.18

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Shanghai Medicilon Inc (688202)

688202 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What was Shanghai Medicilon's net income for the latest quarter?

How did Shanghai Medicilon's performance compare year-over-year in the latest quarter?

What is Shanghai Medicilon's net profit margin on a TTM basis?

How does Shanghai Medicilon's debt to equity ratio compare to industry standards?

What is Shanghai Medicilon's return on investment on a TTM basis?

Did Shanghai Medicilon gain or lose cash last quarter?

What were Shanghai Medicilon's total assets and liabilities in the latest quarter?

How has Shanghai Medicilon's total revenue grown this year?

What is Shanghai Medicilon's gross margin on a TTM basis?

What was Shanghai Medicilon's revenue per share for the latest quarter?

Trending Stocks